null
SMILES: Cc1ccc2c(nn(Cc3c(F)cccc3F)c2n1)-c1nnc2c(NC(=O)C2(C)C)n1
InChI Key: InChIKey=QUWRXOVALRGEAU-UHFFFAOYSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM312957 (3-[1-(2,6-Difluorobenzyl)-6-methyl-1H-pyrazolo[3,4...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine their in vitro action on human PDE 5, the test substances are dissolved in 100% DMSO and serially diluted. Typically, dilution series (1... | US Patent US9605008 (2017) BindingDB Entry DOI: 10.7270/Q2DZ0BC2 | |||||||||||
More data for this Ligand-Target Pair |